At the IATDMCT Stuttgart congress in 2011, Professor Pierre Marquet entered as the new President and presented the results of an inquiry: he’d asked members to describe their innovations and initiatives in Therapeutic Drug Monitoring and Clinical Toxicology, applied at their respective centres. With the updated IATDMCT website, the Communication’s Committee proposed a space for a regular blog of member interviews to gauge clinical innovations, representing different parts of the world as varied as our members. The blog started in 2015, and we have had responses from almost all continents. It has been a pleasure to find out (in a less formal manner compared to published research) what members have been up to. It has also been great to hear about different challenges, and how these were overcome. Finally, it has been great to hear various opinions from these leaders on where they think these fields are headed. |
![]() |
Another fantastic encounter at the congress dinner in Rotterdam was with Dr. Jan Strojil from the Department of Pharmacology of the Faculty of Medicine and Dentistry, Palacký University in Olomouc, Czech Republic. It’s been a pleasure to read about Jan’s passion for teaching, and balancing the demands of academic and clinical life with being a dad. Jan is currently on a fellowship visit with IATDMCT colleagues at the Laboratory of Applied Pharmacokinetics at the University of Southern California.
Jan Strojil |
![]() |
This month’s interview comes from Milan, Italy, from long-term member, colleague and friend Dr. Dario Cattaneo (who wins my vote for best dancer at the wonderful congress dinner at the St Laurence Cathedral in Rotterdam). Dario shares his experiences in the worlds of TDM for immunosuppressant and anti-infective drugs, and how recently these worlds have started to intertwine.
Dario Cattaneo
Photo: Dario and colleagues, IATDMCT Congress dinner, Rotterdam, 13/10/15 |
The content of the IATDMCT Blog does not necessarily have the endorsement of the Association.